Growing interest in HPV vaccination in India

Delhi and Punjab have introduced HPV vaccination and are expanding it, while a few States have shown interest. And the National Technical Advisory Group on Immunisation is considering the introduction of HPV vaccination as part of the Universal Immunisation Programme. After the suspension of the human papillomavirus (HPV) vaccine trial in 2010 carried out on … Continue reading Growing interest in HPV vaccination in India

India turns spotlight on adolescent health

“India has demonstrated very strong leadership in positioning adolescent health as part of continuum of care. India has taken the lead to present to the rest of the States why it is important to have a discussion on adolescent health,” said Dr. Flavia Bustreo, Assistant Director-General of Family, Women’s and Children’s Health, WHO, Geneva. She … Continue reading India turns spotlight on adolescent health

Editorial: HPV trial – Collusion of the worst kind

When regulators become violators, who is to regulate them? That perplexing question is what arises from the damning report of the Parliamentary Standing Committee that investigated alleged irregularities in the conduct of the human papilloma virus vaccine trial on nearly 23,500 girls in the 10-14 age group in Vadodara, Gujarat and Khammam, Andhra Pradesh. But … Continue reading Editorial: HPV trial – Collusion of the worst kind

‘Cancer killed 5.56 lakh people in India in 2010′

Published in The Hindu on May 12, 2012 Cancer killed 5,56,400 people across the country in 2010. The 30-69 age group accounted for 71 per cent (3,95,400) of the deaths. In 2010, cancer alone accounted for 8 per cent of the 2.5 million total male deaths and 12 per cent of the 16 million total … Continue reading ‘Cancer killed 5.56 lakh people in India in 2010′

Editorial: Licensed to kill

Published in The Hindu on April 2, 2012 That tobacco products are singularly responsible for a large number of cancer deaths in adults has once again become strikingly clear. According to a paper published recently in The Lancet, in India, tobacco-related cancers were found in 2010 to be responsible for some 1,20,000 deaths — 84,000 … Continue reading Editorial: Licensed to kill

‘Cancer killed 5.56 lakh in India in 2010’

Published in The Hindu on March 29, 2012 Cancer killed 5,56,400 people across the country in 2010. The 30-69 age group accounted for 71 per cent (3,95,400) of the deaths. In 2010, cancer alone accounted for 8 per cent of the 2.5 million total male deaths and 12 per cent of the 1.6 million total … Continue reading ‘Cancer killed 5.56 lakh in India in 2010’

Editorial: Clinical trials in the dock

Published in The Hindu on February 10, 2012 With the Supreme Court issuing notice to the Central government on the matter of illegal drug trials, the sordid state of human clinical trials is all set to be exposed. For multinational companies eager to cut corners, India offers an attractive package of weak laws, lax and … Continue reading Editorial: Clinical trials in the dock

Editorial: A shockingly unethical trial

Published in The Hindu on May 16, 2011 The question whether all human clinical trials undertaken in India are conducted ethically has been answered. The final report of the three-member committee appointed by the central government to go into the alleged irregularities in the conduct of the human papilloma virus (HPV) vaccine trial reveals gross … Continue reading Editorial: A shockingly unethical trial

Editorial: Battling cervical cancer

Published in The Hindu on April 9, 2009 Cervical cancer, an easily detectable and preventable form of the disease, kills about 50 per cent of the 500,000 women who are infected every year with the human papillomavirus (HPV). Four in five of the infected women are in developing countries, which account for 80 per cent … Continue reading Editorial: Battling cervical cancer

HPV vaccination: key factors studied

Published in The Hindu on September 11, 2008 A formative study was completed recently to understand the various facets of the society and health systems prior to introducing a vaccine that can prevent Human papillomavirus (HPV) infection that is responsible for causing cervical cancer in women. The results of the study were presented to the … Continue reading HPV vaccination: key factors studied